Advent Pharma Ltd. reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported sales was BDT 134.59 million compared to BDT 129.53 million a year ago. Net income was BDT 36.44 million compared to BDT 33.63 million a year ago. Basic earnings per share from continuing operations was BDT 0.3922 compared to BDT 0.3627 a year ago.